nivolumab,lenvatinib,pembrolizumab,fruquintinib,ipilimumab
hutchmed,merck,bms,eisai
['leap002', 'congrat', 'fresco2', 'niche2', '#gi']
au revoir paris #esmo22 lots of compelling data &amp; congrats to all presenters my top 3 #gica abstracts &amp; fave tweet outs niche2 fresco2 leap002 the 2s are coincidental 
Cancer Doctor, Professor, Lifelong Learner #GI #Cancer ???? @UBC @BCCancer @CCTG #Prez @CAMO #TEDxSpeaker #MedTwitter @OncoAlert Tweets are my own